Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

2(29%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_2

14%

Ph not_applicable

14%

Ph phase_1

43%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

3(60.0%)

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(4)

Detailed Status

Completed4

Enrolling by invitation1

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (60.0%)

Phase 21 (20.0%)

N/A1 (20.0%)

Trials by Status

enrolling_by_invitation114%

active_not_recruiting114%

completed457%

recruiting114%

Recent Activity

2 active trials

Showing 5 of 7

active_not_recruitingnot_applicable

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

NCT02740634

enrolling_by_invitation

Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

NCT04680130

recruiting

Imaging Studies in Corticobasal Syndrome

NCT07000851

completedphase_2

Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)

NCT01607476

completedphase_1

PiB PET Scanning in Speech and Language Based Dementias

NCT01623284

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT02740634Not Applicable

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

Active Not Recruiting

NCT04680130

Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

Enrolling By Invitation

NCT07000851

Imaging Studies in Corticobasal Syndrome

Recruiting

NCT01607476Phase 2

Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)

Completed

NCT01623284Phase 1

PiB PET Scanning in Speech and Language Based Dementias

Completed

NCT01723553Phase 1

Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD

Completed

NCT01609335Phase 1

Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7